article thumbnail

Yield10 Bioscience Announces Pricing of $12.7 Million Public Offering – Feb 01, 2021

The Pharma Data

This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Yield10 Bioscience, Inc. Safe Harbor for Forward-Looking Statements.

article thumbnail

The role of machine learning in cancer drug development

Drug Discovery World

Subsequently, the algorithm can model the relationship between genetic sequences and the many factors that influence gene regulation. In doing so, machine learning can be used to parse through the enormous information contained in existing databases to extract promising drug candidates with repurposing potential 4. .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

It contains the antiviral medications nirmatrelvir and ritonavir. Meanwhile, BioMarin’s gene therapy Roctavian is approved by the FDA for the treatment of hemophilia A. Comirnaty was first approved by the US Food and Drug Administration (FDA) in August 2021 for individuals over the age of 16. billion in 2022. Both are anti-CD20 agents.

Sales 98
article thumbnail

Can artificial intelligence help craft new medicines?

Drug Discovery World

Big data handling and machine learning made progress by leaps. Essentially, a biological network is a connected graph of nodes that could represent diseases, genes, proteins, atoms, organs, microorganisms, drugs or ligands. The MorCVD database contains all the human proteins that can be potentially involved in heart disease.